| abstract |
The present invention relates to (a) compounds and salts thereof that inhibit HCV; (b) intermediates for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) preparation of such intermediates , compounds, salts, and compositions; (e) methods of using such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. |